new-kit-box new-kit-box new-kit-box new-kit-box

No-Wash Immunoassay for IFN-β

  • ​Cell-based assay with fast add-and-read protocol
  • Scalable and flexible assay format to meet your needs
  • Luminescent detection with any microplate luminometer

Catalog Number:

Choose a product

Size

$ 597.00

Catalog Number: W1810

Add W1810 to Cart

$ 3,887.00

Catalog Number: W1811

Add W1811 to Cart

$ 2,234.00

Catalog Number: W1812

Add W1812 to Cart

$ 135.00

Catalog Number: W149A-C

Add W149A-C to Cart


to see your price

Solicitar una Muestra

Overview
Protocols
Specifications
Resources
Related Products

Quantify IFN-β Release Without Tedious Wash Steps

IFN-β is an essential mediator of the innate immune response. It has potent antiviral properties, regulates the activity of various immune cells, and exhibits anti-inflammatory effects. IFN-β is used as a therapeutic agent to mitigate inflammation in diseases such as multiple sclerosis.

The Lumit® IFN-β Immunoassay quantitatively measures released IFN-β in cell culture samples using a simple, no-wash protocol. Just add labeled antibodies to the sample, add detection reagent and read luminescent signal using a standard plate-reading luminometer. The entire protocol is completed in less than 70 minutes. The assay can be used directly on cells in culture or culture medium transferred to a separate assay plate.

How the Lumit® IFN-β Immunoassay Works

Primary antibodies to IFN-β were selected for their specific and sensitive detection and labeled with the LgBiT and SmBiT subunits of NanoBiT® Luciferase. In the presence of IFN-β, the subunits are brought together to form an active luciferase enzyme. Addition of optimized substrate generates a bright luminescent signal proportional to IFN-β levels.

Schematic of Lumit™ IL-8 Immunoassay concept showing LgBiT and SmBiT binding protein binding to IL-8 and forming NanoBiT® Luciferase.

Simple One-Plate Protocol Requires No Wash Steps

Lumit™ IL-8 (Human) Immunoassay workflow.

Broad Linear Range of Lumit® IFN-β Detection

The picomolar to nanomolar linear detection range of the Lumit® IFN-β Immunoassay covers expected concentrations for most cell models.

Graph showing standard curve for Lumit® IFN-β (Human) Immunoassay.

Specification

Lumit® IFN-β (Human) Immunoassay

Dynamic Range

18.2–25,000pg/ml

Limit of Detection (LOD)

6.9pg/ml (3 SD above background)

Minimal Detectable Dose (MDD)

4.6pg/ml (2 SD above background)

Assay Time

70 minutes

Sample Type

Cell culture supernatants

SD=Standard Deviation

 

Need to measure a different target?

View our growing portfolio of
Lumit® Immunoassays.

For a biotech that understands time is of significant value, the Lumit® Immunoassays are an essential way for us to gather reliable data fast so that we can reach conclusions and make decisions sooner.

Jonathan Chow, Principal Scientist, Corner Therapeutics

Optimizing the Lumit® IL-6 Immunoassay for High-Throughput Drug Screening

In this webinar, we share key considerations for scaling Lumit® Immunoassays from a single 96-well plate to many 364-well plates and offer tips for optimizing Lumit® Immunoassays for HTS applications. You will also hear Galapagos scientist Dr. Nick Verstraeten share how his team used the Lumit® IL-6 Immunoassay in a screening campaign for antiviral drugs.

View On-Demand Webinar

Lumit® Detection of IFN-β Release from Immune Cells

Line graph showing Lumit® detection of IFN-β release from immune cells.

 

THP-1 cells were plated in 96-well plate format at 50,000 cells/well in RPMI 1640 + 10% heat-inactivated FBS. Cells were treated in triplicate for 40 hours with increasing concentrations of 2′3′-cGAMP. LPS at 1μg/ml was added to some samples for the last 20 hours of treatment. Following treatment, IFN-β release was quantitated using the Lumit® IFN-β Immunoassay.

Specifications

Catalog Number:

Contenido

Item Part # Presentación

Lumit® Detection Substrate B

VB405A 1 × 160μl

Lumit® Detection Buffer B

VB406A 1 × 3.2ml

Anti-hIFN-β mAb-SmBiT, 1000X

W180A 1 × 15μl

Anti-hIFN-β mAb-LgBiT, 1000X

W181A 1 × 15μl

Human IFN-β Standard

W149A 1 × 25μl

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

AA

Patentes y Exclusiones

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 10,648,971 and other patents and patents pending.

Contenido

Item Part # Presentación

Lumit® Detection Substrate B

VB405B 1 × 1.25ml

Lumit® Detection Buffer B

VB406B 1 × 25ml

Anti-hIFN-β mAb-SmBiT, 1000X

W180B 1 × 150μl

Anti-hIFN-β mAb-LgBiT, 1000X

W181B 1 × 150μl

Human IFN-β Standard

W149A 1 × 25μl

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

AA

Patentes y Exclusiones

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 10,648,971 and other patents and patents pending.

Contenido

Item Part # Presentación

Lumit® Detection Substrate B

VB405A 5 × 160μl

Lumit® Detection Buffer B

VB406A 5 × 3.2ml

Anti-hIFN-β mAb-SmBiT, 1000X

W180A 5 × 15μl

Anti-hIFN-β mAb-LgBiT, 1000X

W181A 5 × 15μl

Human IFN-β Standard

W149A 1 × 25μl

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

AA

Patentes y Exclusiones

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 10,648,971 and other patents and patents pending.

Contenido

Item Part # Presentación

Human IFN-β Standard

W149A 1 × 25μl

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

AA